Biobot Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Biobot General Information

Description

Developer of a robotic-assisted prostate intervention system designed to support prostate cancer diagnosis and treatment. The company develops a robotic platform that combines MRI-ultrasound image fusion, robotic needle positioning, and biopsy planning software for transperineal prostate biopsy and soft tissue ablation procedures, enabling healthcare providers to perform precise prostate interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 79 Ayer Rajah Crescent
  • Number 04-05
  • Singapore, 139955
  • Singapore
+65 6351
Primary Industry
Surgical Devices
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Corporate Office
  • 79 Ayer Rajah Crescent
  • Number 04-05
  • Singapore, 139955
  • Singapore
+65 6351

Biobot Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biobot Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Jun-2026 Completed Generating Revenue
8. Later Stage VC (Series C) 09-Apr-2026 Completed Generating Revenue
7. Later Stage VC 14-Apr-2025 Completed Generating Revenue
6. Later Stage VC (Series B) 07-Mar-2024 Completed Generating Revenue
5. Later Stage VC (Series A) 26-Apr-2021 Completed Generating Revenue
4. Seed Round 17-Sep-2018 Completed Generating Revenue
3. Seed Round 29-Jun-2016 Completed Generating Revenue
2. Seed Round 01-Jan-2011 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Biobot’s complete valuation and funding history, request access »

Biobot Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Seed 7,446,935 $0.51 $0.51 1x $0.51 15.08%
Seed 1,678,803 $0.52 $0.52 1x $0.52 3.4%
To view Biobot’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biobot Patents

Biobot Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026235631-A1 Method and system for generating a set of tool trajectories Pending 06-May-2025
WO-2026206264-A1 Method and system for deviation compensation Pending 28-Mar-2025
WO-2026142501-A1 Method and system for generating a biopsy plan Pending 24-Dec-2024
AU-2024433589-A1 A needle guidance system and method Pending 12-Mar-2024
WO-2025193156-A1 A needle guidance system and method Pending 12-Mar-2024 A61B17/3403
To view Biobot’s complete patent history, request access »

Biobot Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biobot Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
ClavystBio Venture Capital Minority
Kupa Corporation Minority
Angel (individual) Minority
PTSM holding Other Minority
You’re viewing 5 of 14 investors. Get the full list »

Biobot Investments (1)

Biobot’s most recent deal was a Joint Venture with Shanghai Intbot Robotics. The deal was made on 21-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Shanghai Intbot Robotics 21-Mar-2021 Joint Venture Machinery (B2B)
To view Biobot’s complete investments history, request access »

Biobot FAQs

  • When was Biobot founded?

    Biobot was founded in 2007.

  • Where is Biobot headquartered?

    Biobot is headquartered in Singapore, Singapore.

  • What is the size of Biobot?

    Biobot has 47 total employees.

  • What industry is Biobot in?

    Biobot’s primary industry is Surgical Devices.

  • Is Biobot a private or public company?

    Biobot is a Private company.

  • What is Biobot’s current revenue?

    The current revenue for Biobot is .

  • How much funding has Biobot raised over time?

    Biobot has raised $54.3M.

  • Who are Biobot’s investors?

    , ClavystBio, Kupa, , and PTSM holding are 5 of 14 investors who have invested in Biobot.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process